Enhanced antitumour efficiency of R₈GD-modified epirubicin plus tetrandrine liposomes in treatment of gastric cancer via inhibiting tumour metastasis

References

• An, J., et al., 2019. EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis. Oncogene, 38 (12), 2123–2134.
   PubMed Web of Science ®Google Scholar
• Bahreyni, A., et al., 2019. A novel MUC1 aptamer-modified PLGA-epirubicin-PbetaAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo. Colloids and surfaces B: biointerfaces, 175, 231–238.
   PubMed Web of Science ®Google Scholar
• Balo, A.R., Lee, J., and Ernst, O.P., 2019. Stationary phase EPR spectroscopy for monitoring membrane protein refolding by conformational response. Analytical chemistry, 91 (1), 1071–1079.
   PubMed Web of Science ®Google Scholar
• Carter, K.A., et al., 2019. Blood interactions, pharmacokinetics, and depth-dependent ablation of rat mammary tumors with photoactivatable. Molecular cancer therapeutics, 18 (3), 592–601.
   PubMed Web of Science ®Google Scholar
• Chen, S., et al., 2017. Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-kappaB/MMP-9 signaling. PLoS one, 12 (3), e0173725.
   PubMed Web of Science ®Google Scholar
• Cheng, G., et al., 2020. Increased formation of reactive oxygen species during tumor growth: Ex vivo low-temperature EPR and in vivo bioluminescence analyses. Free radical biology and medicine, 147, 167–174.
   PubMed Web of Science ®Google Scholar
• Deswaerte, V., et al., 2018. Inflammasome adaptor ASC suppresses apoptosis of gastric cancer cells by an IL18-mediated inflammation-independent mechanism. Cancer research, 78 (5), 1293–1307.
   PubMed Web of Science ®Google Scholar
• Du, Y. and Wei, Y., 2019. Therapeutic potential of natural killer cells in gastric cancer. Frontiers in immunology, 9, 3095.
   PubMed Web of Science ®Google Scholar
• Figiel, S., et al., 2019. A novel calcium-mediated EMT pathway controlled by lipids: an opportunity for prostate cancer adjuvant therapy. Cancers, 11, 1814.
   Web of Science ®Google Scholar
• Fu, M., et al., 2020. Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer. Journal of drug targeting, 28 (3), 245–258.
   PubMed Web of Science ®Google Scholar
• Gomhor, J.H., et al., 2018. Development and characterization of folic acid-functionalized apoferritin as a delivery vehicle for epirubicin against MCF-7 breast cancer cells. Artificial cells, nanomedicine, and biotechnology, 46 (sup3), S847–S54.
   PubMedGoogle Scholar
• Gong, P., et al., 2018. LncRNA UCA1 promotes tumor metastasis by inducing miR-203/ZEB2 axis in gastric cancer. Cell death and disease, 9 (12), 1158.
   PubMed Web of Science ®Google Scholar
• Hu, F., et al., 2019. Inhibition of SIRT2 limits tumour angiogenesis via inactivation of the STAT3/VEGFA signalling pathway. Cell death and disease, 10 (1), 9.
   Google Scholar
• Huang, Y., et al., 2018. Long non-coding RNAs contribute to the inhibition of proliferation and EMT by pterostilbene in human breast cancer. Frontiers in oncology, 8, 629.
   PubMed Web of Science ®Google Scholar
• Hutchins, E.J. and Bronner, M.E., 2019. Draxin alters laminin organization during basement membrane remodeling to control cranial neural crest EMT. Developmental biology, 446 (2), 151–158.
   PubMed Web of Science ®Google Scholar
• Jiang, K., Shen, M., and Xu, W., 2018. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation. International journal of nanomedicine, 13, 2561–2569.
   PubMed Web of Science ®Google Scholar
• Ju, R.J., et al., 2018. Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer. Artificial cells, nanomedicine, and biotechnology, 46 (sup1), 616–628.
   PubMed Web of Science ®Google Scholar
• Li, D., et al., 2018. FOXD1 promotes cell growth and metastasis by activation of vimentin in NSCLC. Cellular physiology and biochemistry, 51 (6), 2716–2731.
   PubMedGoogle Scholar
• Li, X.T., et al., 2016. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells. Oncotarget, 7 (17), 24604–24622.
   PubMed Web of Science ®Google Scholar
• Liu, K.C., et al., 2019a. Development of a novel thermal-sensitive multifunctional liposome with antibody conjugation to target EGFR-expressing tumors. Nanomedicine: nanotechnology, biology, and medicine, 15 (1), 285–294.
   PubMed Web of Science ®Google Scholar
• Liu, X., et al., 2017. Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study. Journal of hematology and oncology, 10 (1), 153.
   PubMedGoogle Scholar
• Liu, X., et al., 2019b. CCL18 enhances migration, invasion and EMT by binding CCR8 in bladder cancer cells. Molecular medicine reports, 19, 1678–1686.
   PubMed Web of Science ®Google Scholar
• Papoff, G., et al., 2018. CASP4 gene silencing in epithelial cancer cells leads to impairment of cell migration, cell-matrix adhesion and tissue invasion. Scientific reports, 8 (1), 17705.
   PubMedGoogle Scholar
• Qi, M., et al., 2018. CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2. Oncogene, 37 (8), 1075–1085.
   PubMed Web of Science ®Google Scholar
• Qu, S., et al., 2019. Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression. Journal of cellular and molecular medicine, 23 (2), 1116–1127.
   PubMed Web of Science ®Google Scholar
• Schneeweiss, A., et al., 2019. Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): a randomised phase III trial. European journal of cancer, 106, 181–192.
   PubMed Web of Science ®Google Scholar
• Shen, Y., et al., 2017. Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer. Oncotarget, 8 (34), 56408–56416.
   PubMedGoogle Scholar
• Song, X., et al., 2018. Self-supplied tumor oxygenation through separated liposomal delivery of H2O2 and catalase for enhanced radio-immunotherapy of cancer. Nano letters, 18 (10), 6360–6368.
   PubMed Web of Science ®Google Scholar
• Song, X.L., et al., 2017. Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer. International journal of nanomedicine, 12, 7433–7451.
   PubMed Web of Science ®Google Scholar
• Tang, M.K.S., Ip, P.P., and Wong, A.S.T., 2018. New insights into the role of soluble E-cadherin in tumor angiogenesis. Cell stress, 2 (9), 236–238.
   PubMedGoogle Scholar
• Wang, X., et al., 2018. Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer. Artificial cells, nanomedicine, and biotechnology, 46 (sup2), 1154–1169.
   PubMed Web of Science ®Google Scholar
• Wu, H., et al., 2017. LncRNA TRERNA1 function as an enhancer of SNAI1 promotes gastric cancer metastasis by regulating epithelial-mesenchymal transition. Molecular therapy - nucleic acids, 8, 291–299.
   Google Scholar
• Wu, Q.N., et al., 2018. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance. Cancer letters, 412, 243–255.
   PubMed Web of Science ®Google Scholar
• Xiang, T., et al., 2018. Vasculogenic mimicry formation in EBV-associated epithelial malignancies. Nature communications, 9 (1), 5009.
   PubMedGoogle Scholar
• Xiao, W., et al., 2015. Tetrandrine induces G1/S cell cycle arrest through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis in vivo. International journal of oncology, 46 (1), 360–368.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., et al., 2018. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. International journal of nanomedicine, 13, 4961–4975.
   PubMed Web of Science ®Google Scholar